General Information
Revision date
2021-11-26
Product name
Multistaining Buffer (20X)
1.2.1 Relevant identified uses
Professional use. Use in laboratories: Research
Emergency telephone
+46 8 525 034 03
Icons in SDS
Company Information
company name
AH Diagnostics A/S
e-mail address of the competent person responsible for the Safety Data Sheet
support-tech@lunaphore.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
H315 - Causes skin irritation. H319 - Causes serious eye irritation. H335 - May cause respiratory irritation.
Prevention
P280 - Wear protective gloves, protective clothing and eye or face protection. P261 - Avoid breathing vapor. P264 - Wash thoroughly after handling.
Response
P304 + P312 - IF INHALED: Call a POISON CENTER or doctor if you feel unwell. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 - If eye irritation persists: Get medical advice or attention.
Storage
Not applicable.
Disposal
Not applicable.
Hazardous Ingredients
trometamol
Supplemental label elements
Not applicable.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Skin Irrit. 2, H315 Eye Irrit. 2, H319 STOT SE 3, H335 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
